Effects of RU486 and spironolactone on pain behavior, Npas4, and
GABAergic markers postoperatively in SPS rats. (a) The PWMT in response
to Dynamic Plantar Aesthesiometer of the right hind paw was measured at
24 h prior to drug or vehicle injection (baseline) and at 6 h to 14 days
after incisional surgery. Statistical analyses were performed using
two-way repeated measures ANOVA, *p < 0.05 versus
control group; #p< 0.05 versus SI + RU486
group; &p < 0.05 versus
SI + spironolactone group (n = 8). (b) After drug or
vehicle treatment, the lumbar spinal cord was homogenized on the 14th
day after incision, and Npas4 mRNA level was analyzed. (c) to (f)
Quantitative RT-PCR performed to detect the mRNA in spinal cord of rats
treated with RU486 or spironolactone before SPS, and sections were
corresponded to GAD65, GAD67, GABAA receptor subunit α1 and γ2,
respectively (n = 4). Data are presented as
mean ± SD, ***p < 0.001,
**p < 0.01, and *p < 0.05;
statistical analysis was performed using one-way ANOVA followed by the
Bonferroni test. SPS: single prolonged stress; Npas4: neuronal PAS
domain protein 4; SI: SPS + incision; PWMT: paw withdrawal mechanical
threshold; ANOVA: analysis of variance; RT-PCR: real-time polymerase
chain reaction.